HomeHealthcareThe regulatory uncertainty surrounding...

The regulatory uncertainty surrounding cannabidiol products does not pose a risk to consumers

Far from being the panacea its marketers claim, CBD has most often been disappointing when evaluated in a real scientific process on humans. “In addition, its use is not without risk, sometimes with serious adverse effects and, above all, the loss of opportunities to choose CBD when there are truly effective treatments.” recalls Pr: Nicolas Autier, Psychiatrist and Head of the Medical Pharmacology and Analgesia Department at Clermont-Ferrand University Hospital.

CBD is regulated under the auspices of Mildeca (the Interagency Mission on Drugs and Addictive Behavior), which, while legally focused on the concept of drugs, is less concerned with other issues. The lack of control over the overall quality of CBD products really increases the risks for users. Only the content of THC, the substance with the amazing properties of hemp, which should not exceed 0.3%, makes…

Source: Le Figaro

- A word from our sponsors -

Most Popular

LEAVE A REPLY

Please enter your comment!
Please enter your name here

More from Author

- A word from our sponsors -

Read Now